Holen Sie sich die Stockscreener-App
16.94
2.53%
-0.44
Handel nachbörslich:
17.28
0.34
+2.01%
Finanzdaten der Kalvista Pharmaceuticals Inc-Aktie (KALV)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-07-31 | 2025-04-30 | 2025-09-30 | 2024-10-31 | 2024-07-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
1.40
|
- | 13.70 | - | - |
Operating Expenses
|
9.82%
60.44
|
55.03 | 59.74 | 45.81 | 44.22 |
| Benefits Costs and Expenses |
59.34
|
- | 61.02 | - | - |
| Costs And Expenses |
59.34
|
- | 61.02 | - | - |
| Operating Income/Loss |
7.23%
-59.01
|
-55.03 | -46.05 | -45.81 | -44.22 |
| Nonoperating Income/Loss |
45.10%
1.07
|
1.949 | -1.275 | 3.543 | 3.772 |
| Income/Loss From Continuing Operations Before Tax |
9.15%
-57.94
|
-53.08 | -47.33 | -42.27 | -40.44 |
| Income Tax Expense/Benefit |
352.28%
2.157
|
-0.855 | 2.157 | - | - |
| Income/Loss From Continuing Operations After Tax |
15.07%
-60.10
|
-52.23 | -49.48 | -42.27 | -40.44 |
|
Net Income/Loss
|
15.07%
-60.10
|
-52.23 | -49.48 | -42.27 | -40.44 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
4,632%
53.50
|
1.1305 | 53.88 | 46.70 | 46.23 |
| Diluted Average Shares |
4,632%
53.50
|
1.1305 | 53.88 | 46.70 | 46.23 |
| Basic Earnings Per Share |
13.13%
-1.12
|
-0.99 | -0.92 | -0.91 | -0.87 |
| Diluted Earnings Per Share |
13.13%
-1.12
|
-0.99 | -0.92 | -0.91 | -0.87 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):